Nuvalent Inc vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Global X NASDAQ 100 Covered Call ETF trades at $17.81. The key difference: Nuvalent Inc is trading nearer its 52-week high, Global X NASDAQ 100 Covered Call ETF nearer its low. Which is the better fit depends on your goals.
| NUVL | QYLD | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $123.96 | $18.52 |
52-Week Low | $72.16 | $16.46 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →